EARLY DETECTION OF DEAFNESS IN A MEMORY CENTER
Launched by UNIVERSITY HOSPITAL, LILLE · Oct 12, 2023
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
The EARLY DETECTION OF DEAFNESS IN A MEMORY CENTER trial, also known as the CogAudio project, is looking to find ways to identify hearing problems early in people who have memory issues, such as mild cognitive impairment. Age-related hearing loss can often go unnoticed, especially when a person is also dealing with cognitive disorders, making it harder to diagnose both conditions. This study will use a specific test to check how well participants can understand speech in noisy environments, which can be a challenge for those experiencing both hearing loss and memory difficulties.
To be eligible for this trial, participants need to be adults aged 18 and older with mild to moderate cognitive impairment, as indicated by a certain score on a memory test. They should be able to speak and understand French and must agree to take part in the study by providing written consent. Each participant will also need to have a study partner to assist them. However, people with a history of serious hearing loss, certain ear conditions, significant psychiatric issues, or major visual impairments will not be able to participate. If enrolled, individuals can expect to undergo assessments to help researchers better understand how hearing and memory problems interact, ultimately aiming to improve diagnosis and treatment for these common age-related issues.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patient with mild to moderate cognitive impairment, with an MMSE score ≥15/30
- • Patient mastering the French language
- • Patient who has given written consent to participate in the trial
- • Socially insured patient
- • Patient willing to comply with all study procedures and duration
- • Patient accompanied by a study partner
- Exclusion Criteria:
- • Medical history of diagnosed deafness, fitted or not
- • History of progressive otological pathology or presence of tympanic obstruction (\>1/3 of the surface of the eardrum)
- • History of unstabilized psychiatric pathology
- • Major visual impairment (Age-Related Macular Degeneration AMD...)
- • Established diagnosis of major language disorders (Primary Progressive Aphasia APP...)
- • Major under legal protection measure
About University Hospital, Lille
University Hospital Lille is a leading academic medical institution dedicated to advancing healthcare through innovative clinical research and patient-centered care. As a prominent sponsor of clinical trials, the hospital leverages its extensive resources, multidisciplinary expertise, and state-of-the-art facilities to facilitate groundbreaking studies across various medical fields. Committed to enhancing therapeutic options and improving patient outcomes, University Hospital Lille collaborates with researchers, healthcare professionals, and industry partners to ensure rigorous scientific standards and ethical practices in all clinical trials.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported